Lunai Bioworks Inc. (LNAI): Total Assets
$9.94M
As of 2026-06-30
-44.5%
3-year compound annual growth
-44.5%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $9.94M | +20.8% | 2026-10-13, Balance as of period end |
| 2025-06-30 | $8.23M | -95.0% | 2026-10-13, Balance as of period end |
| 2024-06-30 | $163.13M | +179.8% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $58.30M | -31.1% | 2025-02-19, Balance as of period end |
| 2022-06-30 | $84.63M | -55.4% | 2023-10-02, Balance as of period end |
| 2021-06-30 | $189.61M | +6.5% | 2023-02-27, Balance as of period end |
| 2020-06-30 | $178.10M | -1.0% | 2021-09-24, Balance as of period end |
| 2019-06-30 | $179.88M | -1.4% | 2020-09-23, Balance as of period end |
| 2018-06-30 | $182.50M | n/c | 2019-09-30, Balance as of period end |
| 2017-06-30 | $4.52M | +419.3% | 2018-10-01, Balance as of period end |
| 2016-06-30 | $870.8K | -58.0% | 2017-11-20, Balance as of period end |
| 2015-06-30 | $2.07M | n/a | 2016-09-28, Balance as of period end |
| 2014-12-31 | $5.24M | n/m | 2015-03-31, Balance as of period end |
| 2013-12-31 | $450.5K | n/a | 2015-03-31, Balance as of period end |
| 2013-03-31 | $20.0K | +47.3% | 2013-07-16, Balance as of period end |
| 2012-03-31 | $13.6K | n/a | 2013-07-16, Balance as of period end |
| 2011-03-31 | $0 | n/a | 2012-07-17, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Lunai Bioworks Inc. (LNAI) | 2026-06-30 | $9.94M | +20.8% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $116.46M | -22.7% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $56.08M | -44.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $74.31M | -34.4% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $279.93M | +100.9% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $2.82M | -17.4% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $7.61M | +2.6% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $340.05M | -30.7% |
Compare LNAI, HCWB, AVTX, CNTB side by side · Screen every company in Pharmaceutical Preparations ↗